Adam Koppel
Director/Board Member chez SOLID BIOSCIENCES INC.
Fortune : 138 730 $ au 31/12/2023
Profil
Adam M.
Koppel is currently serving as an Independent Director at Solid Biosciences, Inc. and as a Managing Director at Bain Capital Life Sciences LP.
He is also an Independent Director at Foghorn Therapeutics, Inc. Additionally, he holds director positions at Cardurion Pharmaceuticals LLC, Cerevel Therapeutics LLC, Cerevel Therapeutics Holdings, Inc., Areteia Therapeutics, Inc., Newton-Wellesley Hospital Corp., and Museum of Science.
Furthermore, he is a Trustee at Newton-Wellesley Health Care System, Inc. In his former roles, Dr. Koppel served as the Chairman of BCLS Acquisition Corp.
He was also a Managing Director at Bain Capital Public Equity LP and held the position of Independent Director at PTC Therapeutics, Inc., ViaCyte, Inc., Dicerna Pharmaceuticals, Inc., Trevena, Inc., Temple Beth Elohim, and Aptinyx, Inc. Additionally, he served as the Chief Strategy Officer & EVP-Business Development at Biogen, Inc. and as an Associate Principal at McKinsey & Co., Inc. He also held a position as Principal at Altus Pharmaceuticals, Inc.Dr. Koppel received his undergraduate and graduate degrees from Harvard University.
He also holds an MBA from The Wharton School of the University of Pennsylvania.
Furthermore, he obtained a doctorate degree from the University of Pennsylvania Medical Center.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
08/01/2024 | 3 282 ( 0,00% ) | 138 730 $ | 31/03/2024 | |
APTINYX INC
-.--% | 24/04/2023 | 0 ( -.--% ) | - $ | 31/12/2023 |
SOLID BIOSCIENCES INC.
-.--% | 06/06/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
29/02/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de Adam Koppel
Sociétés | Poste | Début |
---|---|---|
FOGHORN THERAPEUTICS INC. | Director/Board Member | 01/07/2017 |
CEREVEL THERAPEUTICS HOLDINGS, INC. | Director/Board Member | 01/09/2018 |
SOLID BIOSCIENCES INC. | Director/Board Member | 02/12/2022 |
Newton-Wellesley Health Care System, Inc. | Director/Board Member | - |
Areteia Therapeutics, Inc.
Areteia Therapeutics, Inc. BiotechnologyHealth Technology Areteia Therapeutics, Inc. is a clinical stage biotechnology company that focuses on developing and delivering novel inflammation and immunology therapies for respiratory patients. The company is based in Short Hills, NJ, and the CEO of the company is Jorge Bartolome. The company's initial focus is on developing the first potential oral drug for eosinophilic asthma, with its lead drug candidate being dexpramipexole, a first-in-class oral eosinophil maturation inhibitor. Areteia was created by Population Health Partners and Knopp Biosciences, and a syndicate of leading life sciences and strategic investors has committed to investing up to $350 million in series A financing to establish Areteia and advance dexpramipexole through phase III clinical trials. | Director/Board Member | - |
Cardurion Pharmaceuticals LLC
Cardurion Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cardurion Pharmaceuticals LLC is a cardiovascular biotechnology company, which engages in the development of therapeutics for the treatment of heart failure and cardiovascular diseases. The company was founded by Michael E. Mendelsohn in 2017 and is headquartered in Boston, MA. | Director/Board Member | - |
Museum of Science
Museum of Science Other Consumer ServicesConsumer Services Museum of Science operates as a museum. The company was founded in 1830 and is headquartered in Boston, MA. | Director/Board Member | - |
Newton-Wellesley Hospital Corp.
Newton-Wellesley Hospital Corp. Hospital/Nursing ManagementHealth Services Newton-Wellesley Hospital Corp. provides health care services. Its services include medical, surgical and diagnostic services. The company was founded in 1881 and is headquartered in Newton, MA. | Director/Board Member | - |
Cerevel Therapeutics LLC
Cerevel Therapeutics LLC Pharmaceuticals: MajorHealth Technology Cerevel Therapeutics LLC operates as a biopharmaceutical company focused on developing drug candidates to treat disorders of the central nervous system. The company was founded in 2018 and is headquartered in Boston, MA. | Director/Board Member | - |
░░░░ ░░░░░░░ ░░░░ ░░░░░░░░ ░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
Anciens postes connus de Adam Koppel
Sociétés | Poste | Fin |
---|---|---|
░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
░░░░ ░░░░░░░░░░░ ░░░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
░░░░░ ░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Formation de Adam Koppel
Harvard University | Graduate Degree |
The Wharton School of the University of Pennsylvania | Masters Business Admin |
University of Pennsylvania Medical Center | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 6 |
---|---|
BIOGEN INC. | Health Technology |
PTC THERAPEUTICS, INC. | Health Technology |
TREVENA, INC. | Health Technology |
APTINYX | Health Technology |
SOLID BIOSCIENCES INC. | Health Technology |
FOGHORN THERAPEUTICS INC. | Health Technology |
Entreprise privées | 17 |
---|---|
Bain Capital Public Equity LP
Bain Capital Public Equity LP Investment ManagersFinance Bain Capital Public Equity LP is a SEC-registered investment advisor and hedge fund manager headquartered in Boston, Massachusetts. The firm was founded in 1996 as Brookside Capital LP. They are wholly-owned by Bain Capital LP, itself a subsidiary of Bain Capital Holdings LP. Bain Capital Public Equity provides investment advisory services to pooled investment vehicles (Public Equity Funds). Investors in the Public Equity Funds includes high net-worth individuals, banks, thrift institutions, pension and profit sharing plans, trusts, estates, charitable organizations, university endowments, corporations, limited partnerships and limited liability companies or other business entities. | Finance |
ViaCyte, Inc.
ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology ViaCyte, Inc. develops a stem cell-derived islet replacement therapy for the treatment of diabetes. Its development portfolio includes VC-01 product candidate, a cell replacement therapy for the treatment of type 1 diabetes. The company was founded in 1999 and is headquartered in San Diego, CA. | Health Technology |
Dicerna Pharmaceuticals, Inc.
Dicerna Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Dicerna Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in discovering, developing and commercializing medicines that are designed to leverage ribonucleic acid interference (RNAi) to selectively silence genes that cause or contribute to disease. The firm uses its proprietary GalXC RNAi technology platform to build a pipeline in these therapeutic areas. The company was founded by Douglas M. Fambrough III, Mark A. Behlke, Roberto Guerciolini, James Craig Jenson, and John J. Rossi in October 2006 and is headquartered in Lexington, MA. | Health Technology |
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Commercial Services |
Altus Pharmaceuticals, Inc.
Altus Pharmaceuticals, Inc. BiotechnologyHealth Technology Altus Pharmaceuticals, Inc. develops therapeutic products for gastrointestinal and metabolic diseases. Its principal activity is protein crystallization which is used to develop therapeutic products for gastrointestinal and metabolic diseases. The company was founded in October 1992 and is headquartered in Waltham, MA. | Health Technology |
Newton-Wellesley Hospital Corp.
Newton-Wellesley Hospital Corp. Hospital/Nursing ManagementHealth Services Newton-Wellesley Hospital Corp. provides health care services. Its services include medical, surgical and diagnostic services. The company was founded in 1881 and is headquartered in Newton, MA. | Health Services |
Museum of Science
Museum of Science Other Consumer ServicesConsumer Services Museum of Science operates as a museum. The company was founded in 1830 and is headquartered in Boston, MA. | Consumer Services |
Temple Beth Elohim
Temple Beth Elohim Miscellaneous Commercial ServicesCommercial Services Temple Beth Elohim provides community support services. The non-profit company is based in Wellesley, MA. | Commercial Services |
Bain Capital Life Sciences LP
Bain Capital Life Sciences LP Investment ManagersFinance Bain Capital Life Sciences LP (Bain Capital Life Sciences) is a private equity subsidiary of Bain Capital Private Equity LP, ultimately held by Bain Capital Holdings LP, founded in 2016. The firm is headquartered in Boston, Massachusetts. | Finance |
Cardurion Pharmaceuticals LLC
Cardurion Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cardurion Pharmaceuticals LLC is a cardiovascular biotechnology company, which engages in the development of therapeutics for the treatment of heart failure and cardiovascular diseases. The company was founded by Michael E. Mendelsohn in 2017 and is headquartered in Boston, MA. | Health Technology |
Cerevel Therapeutics LLC
Cerevel Therapeutics LLC Pharmaceuticals: MajorHealth Technology Cerevel Therapeutics LLC operates as a biopharmaceutical company focused on developing drug candidates to treat disorders of the central nervous system. The company was founded in 2018 and is headquartered in Boston, MA. | Health Technology |
BCLS Acquisition Corp.
BCLS Acquisition Corp. Financial ConglomeratesFinance BCLS Acquisition Corp. is a blank check company, which engages in seeking a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was founded on August 26, 2020 and is headquartered in Boston, MA. | Finance |
Cerevel Therapeutics Holdings, Inc. | |
Aavantibio, Inc.
Aavantibio, Inc. BiotechnologyHealth Technology Aavantibio, Inc. engages in developing gene therapies. The company was founded by Barry Byrne and Manuela Corti and is headquartered in Gainesville, FL. | Health Technology |
Cerevel Therapeutics, Inc.
Cerevel Therapeutics, Inc. BiotechnologyHealth Technology Part of Cerevel Therapeutics Holdings, Inc., Cerevel Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company that develops therapies. The private company is based in Cambridge, MA. The company was founded in 2018. N. Anthony Coles has been the CEO of the company since 2018. | Health Technology |
Areteia Therapeutics, Inc.
Areteia Therapeutics, Inc. BiotechnologyHealth Technology Areteia Therapeutics, Inc. is a clinical stage biotechnology company that focuses on developing and delivering novel inflammation and immunology therapies for respiratory patients. The company is based in Short Hills, NJ, and the CEO of the company is Jorge Bartolome. The company's initial focus is on developing the first potential oral drug for eosinophilic asthma, with its lead drug candidate being dexpramipexole, a first-in-class oral eosinophil maturation inhibitor. Areteia was created by Population Health Partners and Knopp Biosciences, and a syndicate of leading life sciences and strategic investors has committed to investing up to $350 million in series A financing to establish Areteia and advance dexpramipexole through phase III clinical trials. | Health Technology |
Newton-Wellesley Health Care System, Inc. |